ResMed Q3 FY26: where the revenue came from and where it went
The whole income statement of ResMed for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 1, 2026
Revenue$1.43B
+11% year over year
Gross profit$0.89B
62% margin
Operating profit$0.50B
35% margin
Net profit$0.40B
28% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.43 | 100% | +11% |
| Sleep & breathing health | 1.26 | 88% | +11% |
| Residential care software | 0.17 | 12% | +6% |
| Cost of revenue | −0.54 | 38% | |
| Gross profit | 0.89 | 62% margin | +3pp |
| R&D | −0.09 | 6% | +0pp |
| SG&A | −0.29 | 20% | +1pp |
| Other | −0.01 | 1% | +0pp |
| Operating profit | 0.50 | 35% margin | +2pp |
| Tax | −0.10 | ||
| Net profit | 0.40 | 28% margin | +0pp |
51 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest